Comparing clot-busting drug versus two blood thinners for small stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a clot-busting drug (rt-PA) or a combination of two blood thinners (DAPT) works better for people having a small stroke caused by a blocked tiny artery in the brain. It aims to find the safest and most effective treatment within the first few hours after symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a stroke caused by a blockage in a very small brain artery, seen on an MRI scan.
- The stroke happened within the last 4.5 hours (or if the exact time is unknown, the last time you were seen well was within 4.5 hours).
- You had no major disability before this stroke (able to do daily activities without help).
- Your stroke symptoms are mild (score of 5 or less on a stroke severity test).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a clot-busting drug given through a vein can help people with certain types of deep brain strokes that happen in small arteries. It looks at patients who can be treated within 24 hours of symptoms starting.
This trial tests whether giving a clot-dissolving medicine (alteplase or tenecteplase) is safe and effective for people who have had a stroke and are taking a blood thinner (DOAC) like apixaban or rivaroxaban. It aims to see if this treatment can still be given within a few hours of the stroke.
This study compares two ways to treat a minor stroke: taking two blood-thinning pills (aspirin and clopidogrel) versus receiving a clot-busting medicine (alteplase) through an IV. The goal is to see which approach works better and has fewer side effects.
This trial tests if giving a second dose of the clot-busting drug tenecteplase can help people whose stroke symptoms don't improve after the first dose, when a large or medium artery in the brain is still blocked. It may be an option for patients who cannot have a mechanical clot removal procedure.
This trial tests whether giving a clot-busting medication (tenecteplase) before the standard clot-removal procedure (thrombectomy) helps patients with a large stroke more than just the procedure alone. If the treatment works, it could improve recovery and reduce disability after a severe stroke.
This study tests whether giving clot-dissolving medication directly into the blocked brain artery (intra-arterial thrombolysis) improves recovery from acute stroke caused by a medium-sized vessel blockage. It aims to see if this treatment helps patients regain function better than standard care.
Hear when a new Lacunar Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.